Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65))

Hope S. Rugo, Jens Huober, José A. García-Sáenz, Norikazu Masuda, Joo Hyuk Sohn, Valerie A.M. Andre, Susana Barriga, Joanne Cox, Matthew Goetz

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)e522
JournalThe oncologist
Volume26
Issue number3
DOIs
StatePublished - Mar 1 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this